Q2 2026 saw strong adjusted EPS and EBITDA growth, driven by margin recovery, disciplined expense management, and successful launch of Insperity HRScale. Full-year guidance was raised, with continued focus on margin recovery, sales momentum, and managing healthcare cost risks.Based on Insperity, In…
Insperity reported second-quarter 2026 results with revenue of $1.686 billion, a 2% increase year-over-year, and adjusted EBITDA of $36 million, up 13% versus Q2 2025. GAAP net income was $4 million and diluted EPS was $0.10 for the quarter; adjusted diluted EPS was $0.34. The company reiterated up…
Q2 2026 saw margin recovery progress, with profitability metrics exceeding forecasts despite a 1% drop in worksite employees. Adjusted EBITDA and EPS rose, and FY 2026 guidance was raised for both. Risks remain from economic and regulatory factors.Original document: Insperity, Inc. [NSP] Slides Rel…
What Happened? A number of stocks fell in the morning session after President Trump declared the Iran ceasefire "over" and threatened fresh strikes, sending oil prices soaring and triggering a broad risk-off move.Business services (staffing, consulting, payment processing, and outsourcing firms) ar…
